378 related articles for article (PubMed ID: 26431342)
1. Cancer statistics: Breast cancer in situ.
Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer: a review of the literature.
Richie RC; Swanson JO
J Insur Med; 2003; 35(2):85-101. PubMed ID: 14733031
[TBL] [Abstract][Full Text] [Related]
4. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
[TBL] [Abstract][Full Text] [Related]
5. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
Bodian CA; Perzin KH; Lattes R
Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540
[TBL] [Abstract][Full Text] [Related]
6. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.
Hussain M; Cunnick GH
Eur J Surg Oncol; 2011 Apr; 37(4):279-89. PubMed ID: 21306860
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).
Nakhlis F; Gilmore L; Gelman R; Bedrosian I; Ludwig K; Hwang ES; Willey S; Hudis C; Iglehart JD; Lawler E; Ryabin NY; Golshan M; Schnitt SJ; King TA
Ann Surg Oncol; 2016 Mar; 23(3):722-8. PubMed ID: 26542585
[TBL] [Abstract][Full Text] [Related]
8. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
Li CI; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
[TBL] [Abstract][Full Text] [Related]
9. Lobular carcinoma in situ: current concepts and controversies.
Schnitt SJ; Morrow M
Semin Diagn Pathol; 1999 Aug; 16(3):209-23. PubMed ID: 10490198
[TBL] [Abstract][Full Text] [Related]
10. Risk of subsequent invasive breast cancer after breast carcinoma in situ.
Wärnberg F; Yuen J; Holmberg L
Lancet; 2000 Feb; 355(9205):724-5. PubMed ID: 10703809
[TBL] [Abstract][Full Text] [Related]
11. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
[No Abstract] [Full Text] [Related]
12. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
Gabriel H
AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
[No Abstract] [Full Text] [Related]
13. Lobular neoplasia: frequency and association with other breast lesions.
Gomes DS; Balabram D; Porto SS; Gobbi H
Diagn Pathol; 2011 Aug; 6():74. PubMed ID: 21827679
[TBL] [Abstract][Full Text] [Related]
14. William Hunter Harridge Lecture: Contemporary management of pre-invasive and early breast cancer.
Bland KI
Am J Surg; 2011 Mar; 201(3):279-89. PubMed ID: 21367364
[No Abstract] [Full Text] [Related]
15. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study.
Maalej M; Hentati D; Messai T; Kochbati L; El May A; Mrad K; Romdhane KB; Ben Abdallah M; Zouari B
Bull Cancer; 2008 Feb; 95(2):E5-9. PubMed ID: 18304901
[TBL] [Abstract][Full Text] [Related]
16. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision.
Lavoué V; Graesslin O; Classe JM; Fondrinier E; Angibeau H; Levêque J
Breast; 2007 Oct; 16(5):533-9. PubMed ID: 17629481
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma-in-situ: an emerging problem in Singapore.
Chua CL; Tan PK; Chiang G; Soo KC; Low CH
Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
[TBL] [Abstract][Full Text] [Related]
18. Current management of noninvasive (in situ) breast cancer.
Silverstein MJ
Adv Surg; 2000; 34():17-41. PubMed ID: 10997214
[No Abstract] [Full Text] [Related]
19. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
[TBL] [Abstract][Full Text] [Related]
20. Trends in the surgical treatment of ductal carcinoma in situ of the breast.
Coleman EA; Kessler LG; Wun LM; Feuer EJ
Am J Surg; 1992 Jul; 164(1):74-6. PubMed ID: 1320805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
